We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Teva Motions Denied In Patent Spat With Pfizer

Law360 (November 8, 2006, 12:00 AM EST) -- In a positive development for Pfizer Inc., Teva Pharmaceuticals Inc.’s pleas to exclude evidence and testimony in its patent dispute over the arthritis painkiller Celebrex were mostly denied by a federal...
To view the full article, register now.